India’s rapidly growing biotechnology industry badly needs funds, specially at the early stages of developing new drugs. It needs to begin filing more original patents in new drugs too, says a new study Beyond Borders Global Biotechnology Report published by Ernst & Young. >>> Discuss This Story
